The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer

Journal of Membrane Biology

Volumn 250, Issue 5, 2017, Pages 455-459

  Gecit, İlhan ^a   Eryılmaz, Recep ^b   Kavak, Servet ^c   Meral, İsmail ^d   Demir, Halit ^b   Pirinççi, Necip ^e   Güneş, Mustafa ^b   Taken, Kerem ^b  

^a INONU UNIVERSITY   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

^c MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

^d BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^e FIRAT UNIVERSITY   (Turkey)

Author keywords

Bladder; Cancer; Nitric oxide; Oxidative stress; Status antioxidants; Superoxide dismutase

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; PROLINE DIPEPTIDASE; SUPEROXIDE DISMUTASE; ENZYME; PANCREAS EXTRACT; PANCRELIPASE; TUMOR PROTEIN;

AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEMATURIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROSPECTIVE STUDY; BLADDER; BLADDER TUMOR; CLINICAL TRIAL; METABOLISM; PATHOLOGY;

ENZYMES; FEMALE; HUMANS; MALE; NEOPLASM PROTEINS; NITRIC OXIDE; OXIDATIVE STRESS; PANCREATIC EXTRACTS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 85027501034     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-017-9971-0     Document Type: Article

References (39)

1. Arikan S, Akcay T, Konukoglu D, Obek C, Kural AR (2005) The relationship between antioxidant enzymes and bladder cancer. Neoplasma 52(4):314–317
2. Arioz DT, Camuzcuoglu H, Toy H, Kurt S, Celik H, Aksoy N (2009) Serum prolidase activity and oxidative status in patients with stage I endometrial cancer. Int J Gynecol Cancer 19(7):1244–1247
3. Batcioglu K, Mehmet N, Ozturk IC et al (2006) Lipid peroxidation and antioxidant status in stomach cancer. Cancer Invest 24:18–21
4. Beutler E, Kuhl W (1975) Subunit structure of human hexosaminidase verified: interconvertibility of hexosaminidase isozymes. Nature (London) 258:262–264
5. Bukan N, Sözen S, Coşkun U, Sancak B, Günel N, Bozkirli I et al (2003) Serum interleukin-18 and nitric oxide activity in bladder carcinoma. Eur Cytokine Net 14(3):163–167
6. Camuzcuoglu H, Arioz DT, Toy H, Kurt S, Celik H, Aksoy N et al (2009) Assessment of preoperative serum prolidase activity in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 147(1):97–100
7. Cechowska-Pasko M, Pałka J, Wojtukiewicz MZ (2006) Enhanced prolidase activity and decreased collagen content in breast cancer tissue. Int J Exp Pathol 87:289–296
8. Cui S, Reichner JS, Mateo RB, Albina JE (1994) Activated murine macrophages induce apoptosis in tumor cells through nitricoxide-dependent or independent mechanisms. Cancer Res 1 54(9):2462–2467
9. Eijan AM, Davel K, Rueda H, Rozenberg G, De Lustig ES, Jasnis MA (1998) Differential nitric oxide release and sensitivity to injury in different murine mammary tumor cell lines. Int J Mol Med 2(5):625–630
10. Ellidag HY, Eren E, Aydın O, Akgol E, Yalcinkaya S, Sezer C et al (2013) Ischemia modified albumin levels and oxidative stress in patients with bladder cancer. Asian Pacifi J Cancer Prevent 14(5):2759–2763
11. Gecit I, Aslan M, Gunes M, Pirincci N, Esen R, Demir H et al (2012) Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer. J Cancer Res Clin Oncol 138(5):739–743
12. Guszczyn T, Sobolewski K (2004) Deregulation of collagen metabolism in human stomach cancer. Pathobiology 71(6):308–313
13. Guyton KZ, Kensler TW (1993) Oxidative mechanisms in carcinogenesis. Br Med Bullet 4983:523–544
14. Jaruga P, Zastawny TH, Skokowski J (1994) Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett 341(1):59–64
15. Karna E, Surazynski A, Palka J (2000) Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale. Int J Exp Pathol 81(5):341–347
16. Kleiner DE, Stetler-Stevenson WG (1999) Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43(Suppl):S42–S51
17. Knowles RG, Moncada S (1994) Nitric oxide synthase in mammals. Biochem J 198:249–258
18. Liu G, Nakayama K, Awata S et al (2007) Prolidase isoenzymes in the rat: their organ distribution, developmental change and specific inhibitors. Pediatr Res 62:54–59
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
20. Macvicar AD (2000) Bladder cancer staging. BJU Int 86:111–122
21. Myara I, Charpentier C, Lemonnier A (1982) Optimal conditions for prolidase assay by proline colorimetric determination: application to imminodipeptiduria. Clin Chim Acta 125:193–205
22. Nishikawa M (2008) Reactive oxygen species in tumor metastasis. Cancer Lett 266:53–59. doi:10.1016/j.canlet.2008.02.031
23. Oberley LW, Bize IB, Sahu SK (1978) Superoxide dismutase activity of normal murine liver, regenerating liver, and H6 hepatoma. J Natl Cancer Inst 61(2):375–379
24. Paglia DE, Valentina WN (1967) studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169
25. Palka J, Surazynski A, Karna E, Orlowski K, Puchalski Z, Pruszynski K et al (2002) Prolidase activity disregulation in chronic pancreatitis and pancreatic cancer. Hepatogastroenterology 49(48):1699–1703
26. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006) Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3(6):327–340
27. Sun Y (1990) Free radicals, antioxidant enzymes and carcinogenesis. Free Radical Biol Med 8(6):583–599
28. Surazynski A, Donald SP, Cooper SK, Whiteside MA, Salnikow K, Liu Y et al (2008) Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 122(6):1435–1440
29. Templar J, Kon SP, Milligan TP, Newman DJ, Raftery MJ (1999) Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol Dial Transplant 14:946–951
30. Tracey JB, Tannenbaum SI, Kavanagh MJ (1995) Applying trained skills on the job: the importance of the work environment. J Appl Psychol 80(2):239–252
31. Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr (2004) Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail Rev 9:53–61
32. Türkdoğan MK, Akman N, Tuncer İ, Dilek FH, Akman H, Memik F et al (1998) The high prevalence of esophageal and gastric cancers in Eastern Turkey. Med Biol Environ 26(1):79–84
33. Wang C, Yu J, Wang H, Zhang J, Wu N (2014) Lipid peroxidation and altered anti-oxidant status in breast adenocarcinoma patients. Drug Research 45:78–98
34. Wolf H, Haeckel C, Roessner A (2000) Inducible nitric oxide synthase expression in human urinary bladder cancer. Virchows Arch 437:662–666
35. Wynder EL, Goldsmith R (1977) The epidemiology of bladder cancer: a second look. Cancer 40:1246–1268
36. Yalcin O, Karatas F, Erulas FA, Ozdemir E (2004) The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. Br J Urol Int 93(6):863–866
37. Yoshimura R, Wada S, Matsuyama M, Hase T, Goto T, Tanaka T et al (2004) Urinary extracellular matrix measurement as a reliable and cost effective diagnostic tool for bladder tumors. Int J Mol Med 13(1):127–131
38. Yoshioka T, Kawada K, Shimada T et al (1979) Lipid peroxidation in maternal and cord blood and protective mechanisms against activated oxygen toxicity in the blood. Am J Obster Gynecol. 135:372–376
39. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA (2004) The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 21:392–401